Cargando…
β-blockers Reverse Agonist-Induced β(2)-AR Downregulation Regardless of Their Signaling Profile
Altered β-adrenergic receptor (β-AR) density has been reported in cells, animals, and humans receiving β-blocker treatment. In some cases, β-AR density is upregulated, but in others, it is unaffected or even reduced. Collectively, these results would imply that changes in β-AR density and β-blockade...
Autores principales: | Maccari, Sonia, Vezzi, Vanessa, Barbagallo, Federica, Stati, Tonino, Ascione, Barbara, Grò, Maria Cristina, Catalano, Liviana, Marano, Giuseppe, Matarrese, Paola, Ambrosio, Caterina, Molinari, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013648/ https://www.ncbi.nlm.nih.gov/pubmed/31947522 http://dx.doi.org/10.3390/ijms21020512 |
Ejemplares similares
-
Crosstalk between β2- and α2-Adrenergic Receptors in the Regulation of B16F10 Melanoma Cell Proliferation
por: Matarrese, Paola, et al.
Publicado: (2022) -
Role of β-Adrenergic Receptors and Estrogen in Cardiac Repair after Myocardial Infarction: An Overview
por: Matarrese, Paola, et al.
Publicado: (2021) -
Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes
por: Buoncervello, Maria, et al.
Publicado: (2019) -
The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013) -
β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)